Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Devonian Health Group, Inc. ( (TSE:GSD) ) has shared an announcement.
Devonian Health Group Inc. has appointed Viktoria Krasteva as Chief Financial Officer, effective February 17, 2025. With her extensive experience in financial markets and strategic leadership in healthcare and technology, Krasteva is expected to guide Devonian through its next growth phase, enhancing its position in the pharmaceutical industry, particularly in developing treatments for inflammatory diseases.
More about Devonian Health Group, Inc.
Devonian Health Group Inc. is a clinical stage pharmaceutical company based in Québec, Canada, focused on developing drugs for auto-immune inflammatory conditions using novel therapeutic approaches. The company also develops cosmeceutical products and operates a subsidiary, Altius Healthcare Inc., for pharmaceutical product commercialization in Canada.
YTD Price Performance: -18.75%
Average Trading Volume: 22,155
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$19.27M
For an in-depth examination of GSD stock, go to TipRanks’ Stock Analysis page.
